Barrington Research Estimates Henry Schein Q1 Earnings

Henry Schein, Inc. (NASDAQ:HSIC) – Barrington Research lowered their Q1 2025 EPS estimates for shares of Henry Schein in a report issued on Thursday, January 30th. Barrington Research analyst M. Petusky now anticipates that the company will post earnings per share of $1.06 for the quarter, down from their previous forecast of $1.12. Barrington Research currently has a “Outperform” rating and a $90.00 price objective on the stock. The consensus estimate for Henry Schein’s current full-year earnings is $4.74 per share. Barrington Research also issued estimates for Henry Schein’s Q2 2025 earnings at $1.20 EPS, Q3 2025 earnings at $1.22 EPS, Q4 2025 earnings at $1.37 EPS and FY2025 earnings at $4.85 EPS.

Henry Schein (NASDAQ:HSIC) last announced its earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to analyst estimates of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. Henry Schein’s revenue was up .4% compared to the same quarter last year. During the same quarter last year, the business earned $1.32 earnings per share.

Several other equities analysts also recently weighed in on the company. Evercore ISI increased their target price on Henry Schein from $70.00 to $74.00 and gave the stock an “in-line” rating in a research report on Tuesday, October 8th. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and increased their price objective for the stock from $69.00 to $84.00 in a report on Monday, January 6th. StockNews.com upgraded shares of Henry Schein from a “sell” rating to a “hold” rating in a report on Thursday, November 7th. Mizuho initiated coverage on shares of Henry Schein in a research note on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price target on the stock. Finally, Jefferies Financial Group lifted their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Seven equities research analysts have rated the stock with a hold rating, five have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $80.10.

Henry Schein Price Performance

HSIC stock opened at $80.00 on Friday. The stock has a market capitalization of $9.97 billion, a price-to-earnings ratio of 32.92, a price-to-earnings-growth ratio of 2.20 and a beta of 0.89. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein has a 52-week low of $63.67 and a 52-week high of $82.63. The stock’s fifty day simple moving average is $73.41 and its 200-day simple moving average is $71.43.

Insiders Place Their Bets

In other news, COO Michael S. Ettinger sold 12,240 shares of Henry Schein stock in a transaction that occurred on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares in the company, valued at $6,577,950. This trade represents a 12.25 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. 1.14% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in Henry Schein in the 4th quarter worth $2,281,000. Venturi Wealth Management LLC lifted its stake in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after acquiring an additional 569 shares in the last quarter. Truist Financial Corp purchased a new position in Henry Schein in the fourth quarter valued at about $257,000. CIBC Asset Management Inc grew its stake in Henry Schein by 1.0% during the 4th quarter. CIBC Asset Management Inc now owns 17,849 shares of the company’s stock valued at $1,235,000 after purchasing an additional 169 shares in the last quarter. Finally, Sanctuary Advisors LLC increased its holdings in Henry Schein by 5.0% during the 4th quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company’s stock worth $294,000 after purchasing an additional 203 shares during the last quarter. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.